153 related articles for article (PubMed ID: 20482687)
1. [Pharmacoeconomy in acne--evaluation of benefit and economics].
Radtke MA; Schäfer I; Augustin M
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S105-14. PubMed ID: 20482687
[TBL] [Abstract][Full Text] [Related]
2. The pharmacoeconomics of acne treatment: where are we heading?
Inglese MJ; Fleischer AB; Feldman SR; Balkrishnan R
J Dermatolog Treat; 2008; 19(1):27-37. PubMed ID: 18273722
[TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
4. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
Kaymak Y; Taner E; Taner Y
Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model.
Wessels F; Anderson AN; Kropman K
S Afr Med J; 1999 Jul; 89(7 Pt 2):791-4. PubMed ID: 10470319
[TBL] [Abstract][Full Text] [Related]
6. Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.
Balkrishnan R; Bhosle MJ; Camacho F; Fleischer AB; Feldman SR
J Dermatolog Treat; 2010 May; 21(3):193-200. PubMed ID: 19895328
[TBL] [Abstract][Full Text] [Related]
7. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
Worret WI; Fluhr JW
J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
[TBL] [Abstract][Full Text] [Related]
8. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
Glazer WM; Ereshefsky L
J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI).
Walker N; Lewis-Jones MS
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):45-50. PubMed ID: 16405607
[TBL] [Abstract][Full Text] [Related]
10. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
Berger K; Ehlken B; Kugland B; Augustin M
J Dtsch Dermatol Ges; 2005 Jul; 3(7):511-8. PubMed ID: 15967010
[TBL] [Abstract][Full Text] [Related]
11. Is prior authorization of topical tretinoin for acne cost effective?
Feldman SR; Fleischer AB; Chen GJ
Am J Manag Care; 1999 Apr; 5(4):457-63. PubMed ID: 10387385
[TBL] [Abstract][Full Text] [Related]
12. Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States.
Patel P; Lin HC; Feldman SR; Fleischer AB; Nahata MC; Balkrishnan R
J Drugs Dermatol; 2011 Jul; 10(7):766-71. PubMed ID: 21720659
[TBL] [Abstract][Full Text] [Related]
13. Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong.
Law MP; Chuh AA; Lee A; Molinari N
Clin Exp Dermatol; 2010 Jan; 35(1):16-21. PubMed ID: 19486044
[TBL] [Abstract][Full Text] [Related]
14. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
15. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
Neubauer AS; Holz FG; Schrader W; Back EI; Kühn T; Hirneiss C; Kampik A
Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
[TBL] [Abstract][Full Text] [Related]
16. The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations.
Harper J
Manag Care Interface; 2005 Mar; 18(3):51-5. PubMed ID: 15816299
[TBL] [Abstract][Full Text] [Related]
17. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
Rogowski WH; Landauer M; John J
Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
19. Large-scale worldwide observational study of adherence with acne therapy.
Dréno B; Thiboutot D; Gollnick H; Finlay AY; Layton A; Leyden JJ; Leutenegger E; Perez M;
Int J Dermatol; 2010 Apr; 49(4):448-56. PubMed ID: 20465705
[TBL] [Abstract][Full Text] [Related]
20. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
